3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
11
Fallopian Tube Neoplasms
8
Sarcoma
3
Sarcoma, Ewing
2
Neoplasms
2
Neoplasm Metastasis
2
Multi-centric Castleman's Disease
2
Breast Neoplasms
2
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Rhabdomyosarcoma
1
Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma
1
Recurrent Epithelial Ovarian, Fallopian or Peritoneal Carcinoma
1
Peritoneal Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Ovarian Cancer Recurrent
1
Osteosarcoma
1
Macular dystrophy, corneal type 1
1
Lymphoproliferative Disorders
1
Lymphadenopathy
1
Liposarcoma
1
Leiomyosarcoma
1
Hodgkin Disease
1
Histiocytoma, Malignant Fibrous
1
HIV Infections
1
Gliosarcoma
1
Glioblastoma
1
Fallopian Tube Mucinous Adenocarcinoma
1
Dermatofibrosarcoma
1
Acquired Immunodeficiency Syndrome
1
Interventions
X-Rays
6
Temozolomide
6
Specimen Handling
6
Nuclear Medicine Department, Hospital
6
Magnetic Resonance Spectroscopy
6
Biopsy
6
Phantoms, Imaging
5
Irinotecan
4
Cyclophosphamide
4
dinutuximab
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
saponin QA-21V1
2
olaparib
2
larotrectinib
2
ivosidenib
2
fludarabine phosphate
2
erdafitinib
2
ensartinib
2
Topotecan
2
trametinib
1
tazemetostat
1
talazoparib
1
palbociclib
1
lutetium Lu 177 dotatate
1
irinotecan sucrosofate
1
fludarabine
1
dabrafenib
1
Vincristine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroblastoma
×
liposomal doxorubicin
×
30 days
×
Clear all
No trials found.